Maximum quantity allowed is 999
请选择数量
CAS RN: 58-32-2 | 产品编码: D2274
Dipyridamole
×
![]()
×
纯度/分析方法: >98.0%(T)(HPLC)
别名：
- 双嘧达莫
- 2,6-双(二乙醇胺)-4,8-二哌啶嘧啶并[5,4-d]嘧啶
- 2,2',2'',2'''-[(4,8-二哌啶基嘧啶并[5,4-d]嘧啶-2,6-二基)二次氮基]四乙醇
- 2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
- 2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakisethanol
产品文档：
补充产品信息:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
技术规格
| Appearance | Light yellow to Yellow to Orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 168 °C |
| 溶解性（可溶于） | 氯仿 |
GHS
| 象形图 |
|
| 信号词 | Danger |
| 危险性说明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. H370 : Causes damage to organs. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P405 : Store locked up. |
相关法规
| RTECS# | KK7450000 |
运输信息
| HS编码* | 2933.99-000 |
应用
Dipyridamole: A Phosphodiesterase (PDE) Inhibitor
Dipyridamole is a phosphodiesterase (PDE) inhibitor.1,2) PDE is a enzyme known to break a phosphodiester bond and degrade cyclic nucleotides. Dipyridamole increases the intracellular levels of cyclic adenosine monophosphate (cAMP) [A2381] and cyclic guanine monophosphate (cGMP) by preventing their conversion to their monophosphates AMP [A0158] and GMP, respectively. Therefore, dipyridamole prevents platelet aggregation by increasing cAMP and cGMP. Furthermore, dipyridamole inhibits the uptake of adenosine into platelets, endothelial cells and erythrocytes. This inhibition results in an increase in local concentrations of adenosine thereby stimulating platelet adenylate cyclase and increasing platelet cAMP levels. In clinical, dipyridamole is used as an antithrombotic agent with antiplatelet activity. Recently, it has been suggested that dipyridamole has beneficial effects for the treatment of COVID-19.3,4) (The product is for research purpose only.)
References
- 1) Dipyridamole (a review)
- 2) Translational therapeutics of dipyridamole (a review)
- 3) Molecular docking reveals the potential of aliskiren, dipyridamole, mopidamol, rosuvastatin, rolitetracycline and metamizole to inhibit COVID-19 virus main protease
- 4) Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
参考文献
TCIMail
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。